Published • loading... • Updated
BlackRock Inc. Invests $42.54 Million in ARS Pharmaceuticals, Inc. $SPRY
Summary by MarketBeat
1 Articles
1 Articles
BlackRock Inc. Invests $42.54 Million in ARS Pharmaceuticals, Inc. $SPRY
BlackRock Inc. bought a new position in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,311,319 shares of the company
·Sioux Falls, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
